期刊论文详细信息
Viruses
Development and Testing of a Method for Validating Chemical Inactivation of Ebola Virus
Anthony Griffiths1  Kendra J. Alfson1 
[1] Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio, TX 78227, USA;
关键词: Ebola virus;    chemical inactivation;    viability testing;    limit of detection;    cytopathic effect;   
DOI  :  10.3390/v10030126
来源: DOAJ
【 摘 要 】

Complete inactivation of infectious Ebola virus (EBOV) is required before a sample may be removed from a Biosafety Level 4 laboratory. The United States Federal Select Agent Program regulations require that procedures used to demonstrate chemical inactivation must be validated in-house to confirm complete inactivation. The objective of this study was to develop a method for validating chemical inactivation of EBOV and then demonstrate the effectiveness of several commonly-used inactivation methods. Samples containing infectious EBOV (Zaire ebolavirus) in different matrices were treated, and the sample was diluted to limit the cytopathic effect of the inactivant. The presence of infectious virus was determined by assessing the cytopathic effect in Vero E6 cells. Crucially, this method did not result in a loss of infectivity in control samples, and we were able to detect less than five infectious units of EBOV (Zaire ebolavirus). We found that TRIzol LS reagent and RNA-Bee inactivated EBOV in serum; TRIzol LS reagent inactivated EBOV in clarified cell culture media; TRIzol reagent inactivated EBOV in tissue and infected Vero E6 cells; 10% neutral buffered formalin inactivated EBOV in tissue; and osmium tetroxide vapors inactivated EBOV on transmission electron microscopy grids. The methods described herein are easily performed and can be adapted to validate inactivation of viruses in various matrices and by various chemical methods.

【 授权许可】

Unknown   

  文献评价指标  
  下载次数:0次 浏览次数:1次